Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Adrenal Insufficiency × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Neoplasms 15 Prostatic Neoplasms 14 Carcinoma, Hepatocellular 10 Multiple Myeloma 9 Lung Neoplasms 9 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Papillomavirus Infections 6 Pain, Postoperative 6 Liver Neoplasms 6 Stomach Neoplasms 5 Leukemia, Myeloid, Acute 5 Recurrence 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Kidney Neoplasms 4 Heart Failure 4 Febrile Neutropenia 4 Brain Neoplasms 4 Warts 3 Vomiting 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Rectal Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-04-09

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡